Lipitor’s sales halved by new generic competition

December 19, 2011 at 11:30 am in Grand Forks Herald

That’s despite a very aggressive effort by Lipitor maker Pfizer Inc. to keep patients on its pill, which generated peak sales of $13 billion a year, through patient subsidies and big rebates to insurers. Lipitor lost patent protection on Nov. 30 in the U.S. Continue Reading